Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients

Lignende værker

• Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study
  af: Guerriero, Fabio, et al.
  Udgivet: (2016)
• Is oxycodone/naloxone effective and safe in managing chronic pain of a fragile elderly patient with multiple skin ulcers of the lower limbs? A case report
  af: Guerriero, Fabio, et al.
  Udgivet: (2015)
• Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
  af: Petrò, Emiliano, et al.
  Udgivet: (2016)
• Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis
  af: Lazzari, Marzia, et al.
  Udgivet: (2015)
• Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
  af: Lazzari, Marzia, et al.
  Udgivet: (2016)